Neuren Pharmaceuticals Annual Report 2025

COVER	1
CHAIR AND CEO MESSAGE	4
OPERATING REVIEW	6
BOARD	23
EXECUTIVE TEAM	24
ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG)	26
DIRECTORS’ RESPONSIBILITIES STATEMENT	33
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME	34
CONSOLIDATED STATEMENT OF FINANCIAL POSITION	35
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY	36
CONSOLIDATED STATEMENT OF CASH FLOWS	37
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS	38
INDEPENDENT AUDITOR’S REPORT	58
ADDITIONAL INFORMATION	61

Made with FlippingBook

RkJQdWJsaXNoZXIy MjE2NDg3